A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phaseNandini Sakurikar, Alan Eastman|Oncotarget|2015Cited by 74
Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunctionJennifer P. Ditano, Alan Eastman|Scientific Reports|2021Cited by 14